Quick Verdict: MEDVi is a Delaware-based telehealth clinic that focuses on compounded GLP-1 medications for weight loss. It offers physician-led consultations, metabolic lab panels, and month-to-month pricing starting at $179 for compounded semaglutide. The platform earns a 4.5/5 on Trustpilot, though BBB complaints about billing and refund disputes suggest the experience is not seamless for everyone. MEDVi is a reasonable option for patients who want a clinically structured GLP-1 program without a long-term contract, but you should understand the limitations of compounded medications before signing up.

Overview

What Is MEDVi?

MEDVi is a telehealth clinic that specializes in GLP-1 receptor agonist medications for weight loss. The company pairs patients with board-certified physicians who evaluate medical history, order lab work, and prescribe compounded versions of semaglutide or tirzepatide when clinically appropriate.

The platform operates entirely online. You complete an intake questionnaire, have a virtual consultation with a physician, and receive medication shipped to your door. MEDVi includes unlimited messaging with your provider and follow-up telehealth visits as part of the monthly subscription.

It is important to understand that MEDVi prescribes compounded medications, not brand-name drugs like Ozempic, Wegovy, or Mounjaro. Compounded GLP-1s use the same active molecules but are prepared by compounding pharmacies. These formulations are not FDA-approved and may differ in concentration, formulation, and quality from their brand-name counterparts.

Pricing in 2026

MEDVi's pricing structure is straightforward compared to some competitors:

• Compounded semaglutide: $179 for the first month, $299/month for ongoing refills
• Compounded tirzepatide: $279 to $349 for the first month, depending on dose and formulation

The monthly price covers the physician evaluation, a personalized treatment plan, metabolic health report, medication supply, and shipping. There is no separate enrollment fee or consultation charge.

MEDVi operates on a cash-pay basis and does not accept insurance. Patients can attempt to use HSA or FSA cards, but coverage through these accounts is not guaranteed and depends on your specific plan.

Compared to competitors, MEDVi sits in the mid-range. Hims offers compounded semaglutide starting at $199/month, while some smaller clinics charge $350 or more. The first-month introductory rate of $179 is competitive, but the jump to $299/month for ongoing treatment is worth factoring into your budget.

Medications and Treatment

MEDVi offers two primary medication options:

Compounded semaglutide is the more common choice. Semaglutide is the same active ingredient found in Ozempic and Wegovy. MEDVi's physicians typically start patients on a lower dose and titrate up over several weeks to manage side effects.

Compounded tirzepatide is also available. Tirzepatide is a dual GIP/GLP-1 receptor agonist (the same active ingredient in Mounjaro and Zepbound) that some research suggests may produce greater weight loss than semaglutide alone.

Both medications are administered via subcutaneous injection. MEDVi includes injection supplies and instructions with each shipment.

The treatment plan also includes metabolic lab panels. This is one area where MEDVi differentiates itself from leaner competitors. The lab work gives physicians a fuller picture of your metabolic health, which can help guide dosing decisions and identify potential contraindications.

Provider Quality

MEDVi emphasizes its physician-led model. Consultations are conducted by board-certified doctors rather than nurse practitioners or physician assistants. For most patients starting a straightforward GLP-1 protocol, the distinction between an MD and an NP is not clinically significant. However, patients with complex medical histories, multiple medications, or comorbid conditions may benefit from physician oversight.

Patient feedback on provider interactions is generally positive. Many reviews note that initial consultations feel thorough and unhurried. Follow-up communication tends to be more personalized than what you get from larger platforms, though MEDVi operates on business-hours response times rather than 24/7 messaging.

Patient Experience and Platform

MEDVi's patient portal is functional but not flashy. You can message your provider, manage your subscription, and track shipments through the portal. It handles the basics without the polished app experience offered by larger competitors like Hims.

Shipping is free and typically arrives within a few business days. Some patients have reported occasional delays during periods of high demand, which is a common issue across the compounded GLP-1 space when pharmacy capacity is strained.

Pros

• No long-term contract; cancel anytime on a month-to-month basis
• Physician-led consultations with board-certified doctors
• Comprehensive metabolic lab panels included
• Competitive first-month pricing at $179 for semaglutide
• Both semaglutide and tirzepatide options available
• Free shipping on all orders
• Results-based guarantee after 5 months of adherence

Cons

• Ongoing semaglutide cost of $299/month is higher than some competitors
• Only compounded medications; no brand-name GLP-1s available
• Does not accept insurance
• Patient portal lacks the polish of larger platforms
• BBB complaints cite billing issues, unauthorized charges, and refund difficulties
• Refund policy has significant restrictions (5-month minimum, 25% consultation deduction)
• Business-hours-only provider communication

Who Is MEDVi Best For?

MEDVi is best suited for patients who want a physician-supervised GLP-1 program with structured metabolic tracking and do not want to commit to a long-term contract. It works well for people who prefer the clinical depth of working with a board-certified physician over the streamlined, app-first approach of larger telehealth companies.

It is less ideal for budget-conscious patients who are comparing monthly costs across platforms, or for anyone who needs brand-name medications covered by insurance.

Frequently Asked Questions

Is MEDVi a legitimate company?

Yes. MEDVi is a registered telehealth company based in Newark, Delaware. It works with licensed physicians and partners with compounding pharmacies to fill prescriptions. It has a 4.5/5 rating on Trustpilot based on thousands of reviews, though it also has complaints on file with the BBB.

Does MEDVi prescribe brand-name Ozempic or Wegovy?

No. MEDVi prescribes compounded versions of semaglutide and tirzepatide. These use the same active ingredients as brand-name drugs but are not FDA-approved products.

Can I cancel MEDVi at any time?

MEDVi operates on a month-to-month basis with no long-term contract. You can cancel through your patient portal or by contacting customer support. Cancel before your renewal date to avoid being charged for the next month.

Does MEDVi accept insurance?

No. MEDVi is a cash-pay platform. HSA and FSA cards may be accepted, but coverage depends on your individual plan.

What is MEDVi's refund policy?

MEDVi offers a results-based guarantee: if you follow the program for at least five months without losing weight, you may qualify for a refund minus a 25% consultation fee. Once a prescription has been issued, standard refunds are generally not available.

Looking for physician-supervised GLP-1 therapy with transparent pricing and no long-term commitment? Form Blends offers telehealth consultations with licensed physicians, compounded and brand-name medication options, and flexible month-to-month plans. Learn more about Form Blends.